Patents by Inventor Scott Ibrahim

Scott Ibrahim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gastric release pulse system for drug delivery
    Patent number: 9125803
    Abstract: Disclosed are pharmaceutical products for providing pulses of at least one pharmaceutically active ingredient from a patient's stomach, or from a subsequent gastrointestinal site proximal thereto, for absorption thereof at a site(s) more distal in the gastrointestinal tract than the patient's stomach, or than the subsequent gastrointestinal site proximal thereto. The product comprises first, second, and third pharmaceutical dosage forms, each of which comprises at least one pharmaceutically active agent and a pharmaceutically acceptable carrier. The product is formulated such that at least two of the first, second, and third pharmaceutical dosage forms further comprise means for providing temporary gastric-retention of the at least two of the first, second, and third pharmaceutical dosage forms within the patient's stomach, or at the subsequent gastrointestinal site proximal thereto.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: September 8, 2015
    Assignee: Shionogi Inc.
    Inventors: Henry H. Flanner, Donald Treacy, Sanna Tolle-Sander, Scott Ibrahim, Marcus Schestopol, Beth A. Burnside
  • CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE
    Publication number: 20140037745
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: September 24, 2013
    Publication date: February 6, 2014
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • Controlled release compositions of gamma-hydroxybutyrate
    Patent number: 8598191
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: December 3, 2013
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE
    Publication number: 20120231085
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: May 21, 2012
    Publication date: September 13, 2012
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • Controlled release compositions of gamma-hydroxybutyrate
    Patent number: 8193211
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: June 5, 2012
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • Gastric release pulse system for drug delivery
    Publication number: 20070154547
    Abstract: Disclosed are pharmaceutical products for providing pulses of at least one pharmaceutically active ingredient from a patient's stomach, or from a subsequent gastrointestinal site proximal thereto, for absorption thereof at a site(s) more distal in the gastrointestinal tract than the patient's stomach, or than the subsequent gastrointestinal site proximal thereto. The product comprises first, second, and third pharmaceutical dosage forms, each of which comprises at least one pharmaceutically active agent and a pharmaceutically acceptable carrier. The product is formulated such that at least two of the first, second, and third pharmaceutical dosage forms further comprise means for providing temporary gastric-retention of the at least two of the first, second, and third pharmaceutical dosage forms within the patient's stomach, or at the subsequent gastrointestinal site proximal thereto.
    Type: Application
    Filed: December 22, 2006
    Publication date: July 5, 2007
    Inventors: Henry H. Flanner, Donald Treacy, Sanna Tolle-Sander, Scott Ibrahim, Marcus Schestopol, Beth A. Burnside
  • Controlled release compositions of gamma-hydroxybutyrate
    Publication number: 20060210630
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: September 30, 2005
    Publication date: September 21, 2006
    Inventors: Likan Liang, Niraj Shah, Padmanabh Bhatt, Scott Ibrahim